Budesonide Treatment for Lymphocytic Colitis

• Status: Completed
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Technische Universität Dresden
• Collaborator: Dr. Falk Pharma GmbH
• Treatments: Budesonide

Criteria

Inclusion Criteria:

• lymphocytic colitis

• diarrhea

• effective contraception

• written informed consent

Exclusion Criteria:

• other forms if IBD

• celiac disease

• infectious colitis

• history of colonic surgery

• use of budesonide, 5-ASA, steroids within th previous 4 weeks

• pregnancy, lactation